Additional infections of concern include HIV1 and Hepatitis C virus. With regards to occupational exposure, benzene and electromagnetic field exposure have shown a strong association with LBL development [1] . T-LBL is less common than T-cell Acute
Lymphoblastic Leukemia (T-ALL) and is often defined by the confinement of the neoplasm within a mass with minimal blood or bone marrow involvement [2] .
Diagnostic criteria include the presence of blast cells in peripheral blood smear, tissue biopsy, and/or bone marrow biopsy.
In the peripheral smear the lymphoblasts are identified as small cells with scant cytoplasm and condensed nuclear chromatin, but may also be larger cells with ample cytoplasm, dispersed chromatin, and many nuclei. Tissue biopsy would show lymphoblasts in a diffuse, lymph node, or paracortical pattern. Though rare, it is also possible to see nodules that resemble follicular lymphoma with or without eosinophils infiltrating the lymph nodes. Histochemical analysis shows positive staining for TdT as a marker of lymphoid progenitor cell origin, with variable expression of CD1a, CD2, CD3, CD4, CD5, CD7, and CD8. While T-LBL and T-ALL are similar in many ways, T-LBL usually demonstrates a more mature immunophenotype [3] .
Those with T-LBL are likely to present with cervical, supraclavicular, and axillary lymphadenopathy with or without mediastinal mass [4] . It is a clinically aggressive disease with patients usually presenting at stage IV with B symptoms such as fever, night sweats, and weight loss, and frequently with elevated LDH. At initial presentation bone marrow is usually normal but that does not preclude infiltration in a later stage Figure 3 .
The German Multicenter Trials for Adult Acute Lymphoblastic
Leukemia (GMALL) showed the only significant prognostic factor for survival in T-LBL was elevated LDH, which was present in our patient. Multiple mutations have been identified to play a role in the development of T-LBL, including activating mutations in NOTCH1
(which encodes for transmembrane protein) or inactivating mutations of FBXW7 which negatively regulates NOTCH.
Additionally, dysregulated expression of HOX11, TLX1, TAL1, LYL1, LMO1, and LMO2 were associated with mutation arrest at known stages of normal thymic development [2] . The GMALL also showed that Notch/FBXW7 mutation (without RAS/PTEN mutation/ deletion) could be considered a favorable prognostic factor. 
